| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5715ab06de4672167063959fb28baffb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2c99ad962aab260a349acc51e23c44c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 |
| filingDate |
2001-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77102d3677652c57ff00c1db87c68baa |
| publicationDate |
2002-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0250546-A2 |
| titleOfInvention |
Method and use of the cytosolic nadp-dependent malate-decarboxylase isoenzyme for identifying a malignant process, and a suitable test kit |
| abstract |
The invention relates to a method for identifying a malignant process in the body and/or in the gastro-intestinal tract of humans or animals, in addition to a test kit for carrying out the inventive method for identifying cytosolic NADP-dependent malate-decarboxylase in human or animal bodily fluids or in human or animal stools. The invention also relates to monoclonal antibodies which specifically bind the cytosolic NADP-dependent malate-decarboxylase and do not cross react with any other malate-decarboxylase isoenzymes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102012013888-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014008884-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9766243-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-202012012084-U1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108611330-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102018000815-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102016015060-A1 |
| priorityDate |
2000-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |